Kestra Advisory Services’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $750K | Buy |
|
|||||
|
2025
Q2 | $353K | Buy |
|
|||||
|
2025
Q1 | $259K | Sell |
|
|||||
|
2024
Q4 | $373K | Buy |
|
|||||
|
2024
Q3 | $358K | Sell |
|
|||||
|
2024
Q2 | $338K | Buy |
|
|||||
|
2024
Q1 | $203K | Buy |
|
|||||
|
2023
Q4 | $243K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $214K | Sell |
|
|||||
|
2022
Q4 | $556K | Buy |
|
|||||
|
2022
Q3 | $324K | Buy |
|
|||||
|
2022
Q2 | $207K | Buy |
|
|||||
|
2022
Q1 | $219K | Buy |
|
|||||
|
2021
Q4 | $215K | Sell |
|
|||||
|
2021
Q3 | $510K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $639K | Buy |
|